Stage

Seed VC | Alive

Total Raised

$3.1M

Last Raised

$3.1M | 1 yr ago

About Fitterfly

Fitterfly offers scientific and personalized digital therapeutics (DTx) programs for diabetes, pregnancy, PCOS, and weight loss. The company uses smart technology and science to help people with diabetes, pregnancy, PCOS, obesity, and many more conditions achieve their health goals. The diabetes management program, Diabefly, has proven to reduce HbA1c in 85% of customers.

Fitterfly Headquarter Location

503, Akshar Blue Chip Corporate Park Turbhe MIDC

Navi Mumbai, 400705,

India

022 48971077

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Fitterfly's Products & Differentiation

See Fitterfly's products and how their products differentiate from alternatives and competitors

  • Diabefly Pro

    Diabefly is a digital therapeutic program aimed at preventing, managing and reversing diabetes.

    Differentiation

    Diabefly is our flagship DTx for Diabetes & Prediabetes. The program uses 1300+ blood sugar readings from CGMS devices and generates personalised glycemic response (rise in blood sugar) with each fo… 

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

Expert Collections containing Fitterfly

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Fitterfly is included in 3 Expert Collections, including Digital Health.

D

Digital Health

13,495 items

Companies developing and enabling evidence-based, software-driven therapeutic interventions to prevent, manage, or treat a medical disorder or disease. (*Scope follows the Digital Therapeutics Alliance definition)

D

Diabetes

1,750 items

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Latest Fitterfly News

Roche Diabetes Care and Fitterfly partner to improve outcomes

Apr 28, 2022

A+ Mumbai (Maharashtra) [India], April 28 (ANI/PRNewswire): Roche Diabetes Care India (RDC) and Fitterfly Healthtech, India’s leading Digital Therapeutics (DTx) company have partnered to co-create a 90-day diabetes management programme for people with type 2 diabetes. This programme is aimed at enhancing therapy adherence and improving outcomes, and bringing true relief to people with diabetes. The program is designed to give instant insights on blood sugar, in-depth assessments and personalised plans for nutrition, fitness and wellness to provide best-in-class outcomes. This is best suited for individuals with newly diagnosed type 2 diabetes, new and fast-changing prescriptions on insulin or those who have spotted new symptoms indicating long-term complications of diabetes. Speaking of the collaboration, Dr. Arbinder Singal, Co-founder & CEO of Fitterfly added, “We are very excited to embark on this journey with Roche Diabetes Care India, who share our outcome-focused approach towards the treatment of diabetes. The programme is designed to study the effects of various food groups on blood sugars with our unique meal-mapping technology. We help supplement medical treatment with nutrition, fitness and stress management solutions that have been proven to reduce blood sugar. The members of the programme will be able to benefit from the accuracy and personalised approach of the programme bridging the important gap of lifestyle management and long-term behaviour change that is crucial to medical management prescribed by doctors.” Speaking about the programme, Omar Sherief Mohammad, Cluster Head, India Middle East and Africa, Roche Diabetes Care said, “Creating a robust and supportive eco-system plays a vital role in enabling effective diabetes management. This includes forming a combination of monitoring, therapy, diet and lifestyle guidance. Technology acts as an enabler here by bringing in advanced analytics and by enhancing the reach of this ecosystem such that more people are within the circle of care. We are proud to partner with Fitterfly, who not only has the right technology but also shares our purpose of improving access to diabetes care. Through this programme we believe we can generate real-world evidence to showcase the importance of comprehensive care in enhancing therapy adherence and improving outcomes.” Fitterfly was selected as part of Roche’s Startup Creasphere APAC programme from among >40 startups in digital health for its clinical validation, personalised, and 360° approach to type 2 diabetes management. For further information and to enroll in the programme visit https://www.fitterfly.com/health/diabefly- accu-chek or call on +91 8047091686 *SMBG: Self-Monitoring of Blood Glucose **bgms: Blood Glucose Monitoring Systems ***bg: Blood Glucose Fitterfly is a smart, personal digital therapeutic solution that is an anytime, anywhere companion for patients to truly achieve their health goals. The company offers clinically validated, digital-led therapy that connects patients, health coaches, and healthcare providers in meaningful ways to enable sustainable behavior change that is at the core of good health. Fitterfly achieves transformational outcomes for patients with personalized, data and coaching-led behavior change via Vogital (voice and digital) touchpoints with a user-centric app. The programmes are based on glocally accepted, evidence-based protocols, and cutting-edge research. Fitterfly’s current product suite includes scientific and hyper-personalized DTx programmes for Type 2 diabetes, prediabetes, and obesity. They are the preferred digital therapeutic partner for many doctors, hospitals, organizations like pharma companies, corporates, and medical device companies. Fitterfly was cofounded by Dr. Arbinder Singal- CEO and Shailesh Gupta- COO Roche Diabetes Care has been pioneering innovative diabetes technologies and services for more than 40 years. More than 5,500 employees in over 100 markets worldwide work every day to support people with diabetes and those at risk to achieve more time in their target ranges and experience true relief from the daily therapy routines. Being a global leader in integrated Personalised Diabetes Management (iPDM), Roche Diabetes Care collaborates with thought leaders around the globe, including people with diabetes, caregivers, healthcare providers and payers. Roche Diabetes Care aims to transform and advance care provision and foster sustainable care structures. Under the brands RocheDiabetes, Accu-Chek and mySugr, comprising glucose monitoring, insulin delivery systems and digital solutions, Roche Diabetes Care unites with its partners to create patient-centred value. By building and collaborating in an open ecosystem, connecting devices and digital solutions as well as contextualise relevant data points, Roche Diabetes Care enables deeper insights and a better understanding of the disease, leading to personalised and effective therapy adjustments. For better outcomes and true relief. Since 2017, mySugr one of the most popular diabetes management apps is part of Roche Diabetes Care. For more information, please visit www.rochediabetes.com , www.accu-chek.com and www.mysugr.com . Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. More than thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the eleventh consecutive year, Roche has been recognised as one of the most sustainable companies in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI). The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2019 employed about 98,000 people worldwide. In 2019, Roche invested CHF 11.7 billion in R&D and posted sales of CHF 61.5 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com . All trademarks used or mentioned in this release are protected by law. This story is provided by PRNewswire. ANI will not be responsible in any way for the content of this article. (ANI/PRNewswire) This story is auto-generated from a syndicated feed. ThePrint holds no responsibility for its content. Subscribe to our channels on YouTube & Telegram Why news media is in crisis & How you can fix it India needs free, fair, non-hyphenated and questioning journalism even more as it faces multiple crises. But the news media is in a crisis of its own. There have been brutal layoffs and pay-cuts. The best of journalism is shrinking, yielding to crude prime-time spectacle. ThePrint has the finest young reporters, columnists and editors working for it. Sustaining journalism of this quality needs smart and thinking people like you to pay for it. Whether you live in India or overseas, you can do it here .

Fitterfly Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Fitterfly Rank

  • Where is Fitterfly's headquarters?

    Fitterfly's headquarters is located at 503, Akshar Blue Chip Corporate Park, Navi Mumbai.

  • What is Fitterfly's latest funding round?

    Fitterfly's latest funding round is Seed VC.

  • How much did Fitterfly raise?

    Fitterfly raised a total of $3.1M.

  • Who are the investors of Fitterfly?

    Investors of Fitterfly include Fireside Ventures, Venture Catalysts and 9Unicorns.

  • Who are Fitterfly's competitors?

    Competitors of Fitterfly include Twin Health and 1 more.

  • What products does Fitterfly offer?

    Fitterfly's products include Diabefly Pro and 4 more.

You May Also Like

G
GAIA

GAIA is a global digital therapeutics company on a mission is to develop digital therapy solutions that offer physicians, therapists, payers and patients the same effect sizes, similar safety profiles and equal levels of convenience as found in well-developed, pharmaceutical solutions.

GOQii Logo
GOQii

GOQii integrates wearable technology, personalized coaching, and elements of social philanthropy to encourage users to make a sustainable shift towards a healthier and more fulfilling lifestyle. The GOQii social feature lets users discover and make friends, share fitness stories, and motivate each other.

L
Lori

Lori provides a mobile platform to manage cholesterol issues, hypertension, and diabetes.

WellDoc Logo
WellDoc

WellDoc is a healthcare behavioral science and technology company that focuses on simplifying the way chronic diseases are managed through a collaborative approach that breaks down the barriers of engagement and adherence by providing patients and healthcare providers with real-time information. WellDoc has developed a technology-based solution designed to help people with chronic diseases better manage conditions. The flagship product, DiabetesManager, provides a system for patients and health care providers to coordinate diabetes care, propel self-management and achieve long-term adherence.

Omada Health Logo
Omada Health

Omada Health is a digital behavioral medicine company that helps people to change the habits that put them most at risk for serious but largely preventable chronic conditions like heart disease and type 2 diabetes. The company brings behavioral counseling to anyone with an Internet connection, using insights about social networking, gaming, and behavioral science to motivate changes in lifestyle and deliver clinically-meaningful results.

Virta Health Logo
Virta Health

Virta Health develops a clinically-proven treatment to safely and sustainably reverse type 2 diabetes and other chronic metabolic diseases without the use of medications or surgery.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.